Ribosome-binding protein 1: A multidimensional regulator of cancer progression and a novel target for precision therapy (Review).

Although these comparisons did not reach statistical significance (log-rank P>0.05), the consistent direction of the curves suggested potential biological relevance.

also in 111,027 other papers

Similarly, in skin cutaneous melanoma, patients with RRBP1 alterations also showed a trend toward improved OS, disease-specific survival and progression-free survival ( Fig. 5D-F ).

also in 53,322 other papers